Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ARTD Therapeutics Oy
OY
Active
Y-tunnus 2789413-9
Hakekatu 2-B10
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2016
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2023
EUR 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2023
EUR 0
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2019
0M
0%
2020
0M
0%
2023
Key figures
Annual report 2023
Revenue
EUR 0
—
EBITDA
EUR 0
—
Net profit
EUR 0
—
Total assets
EUR 0
—
Equity
EUR 0
—
Employees
—
—
Company information
Legal name
ARTD Therapeutics Oy
Y-tunnus number
2789413-9
Legal form
Osakeyhtiö
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
19. lokakuuta 2016
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on kemiallisten yhdisteiden tutkiminen, kehittäminen, patentointi, osto ja myynti lääketeollisuuden tarpeisiin.
Contact
Address
Hakekatu 2-B10
Phone
+358443067665
Email
yves.nkizinkiko@oulu.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Oulu
All Finland companies
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2023
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
0M
2023
Income statement
EUR thousands
Item
2019
2020
2023
Revenue
0
0
0
Staff expenses
—
—
−0
EBITDA
0
0
0
Depreciation & amort.
—
—
−0
EBIT
0
0
0
Net financials
—
—
0
Profit before tax
0
0
0
Tax
−0
−0
−0
Net profit
0
0
0
Balance sheet
EUR thousands
Item
2019
2020
2023
Total assets
0
0
0
Equity
0
0
0
Long-term debt
—
—
0
Short-term debt
—
—
0
Total debt
—
—
0
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2019
2023
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
2019
2023
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2019
2023
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2019
2023
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2019
2023
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
2019
2023
Annual reports & filings
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2020
Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
YN
Yves Nkizinkiko
Chief Executive Officer
Chief Executive Officer
2016
Former (1)
HT
Hannu Tapio Tuomaala
Deputy Member
Deputy Member
2016 – 2025
Board of directors
Non-executive oversight
Name
Role
Member since
Former (1)
LT
Lauri Tapio Aukusti Löwenmark
Board of Directors
2016 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of ARTD Therapeutics Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Hannu Tapio Tuomaala
Deputy Member
0 companies
Yves Nkizinkiko
Chief Executive Officer
0 companies
Lauri Tapio Aukusti Löwenmark
Board of Directors
0 companies